Matti Itkonen

Person

Latest publications

  1. Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In Humans

    Itkonen, M. K., Tornio, A., Neuvonen, M., Neuvonen, P. J., Niemi, M. & Backman, J. T., 1 Apr 2019, In : Drug Metabolism and Disposition. 47, 4, p. 377-385 9 p.

    Research output: Contribution to journalArticleScientificpeer-review

  2. Response to "Interaction of Dasabuvir With Clopidogrel: Did Predictions by Physiologically Based Pharmacokinetics Modeling Pass the Test?"

    Itkonen, M. K., Tornio, A., Lapatto-Reiniluoto, O., Neuvonen, M., Neuvonen, P. J., Niemi, M. & Backman, J. T., Feb 2019, In : Clinical Pharmacology and Therapeutics. 105, 2, p. 322-322 1 p.

    Research output: Contribution to journalLetterScientific

  3. Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel

    Itkonen, M. K., Tornio, A., Lapatto-Reiniluoto, O., Neuvonen, M., Neuvonen, P. J., Niemi, M. & Backman, J. T., Jan 2019, In : Clinical Pharmacology and Therapeutics. 105, 1, p. 219-228 10 p.

    Research output: Contribution to journalArticleScientificpeer-review

View all (8) »

Latest activities

  1. Improving Rational Pharmacotherapy - 50 Years of Clinical Pharmacology in Finland symposium

    Matti Itkonen (Speaker)
    8 Nov 20189 Nov 2018

    Activity: Talk or presentation typesOral presentation

  2. Nordic Drug Information Meeting

    Matti Itkonen (Attendee)
    24 Sep 201825 Sep 2018

    Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

  3. First Nordic Conference on Personalized Medicine

    Matti Itkonen (Poster Presentation)
    30 May 20181 Jun 2018

    Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

View all (12) »

ID: 35588644